[Current immunotherapy of multiple sclerosis].

about

[Current immunotherapy of multiple sclerosis].

Item

http://www.wikidata.org/entity/Q52863422

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

[Current immunotherapy of multiple sclerosis].

@en

[Current immunotherapy of multiple sclerosis].

@nl

type

Item

label

[Current immunotherapy of multiple sclerosis].

@en

[Current immunotherapy of multiple sclerosis].

@nl

prefLabel

[Current immunotherapy of multiple sclerosis].

@en

[Current immunotherapy of multiple sclerosis].

@nl

P1476

[Current immunotherapy of multiple sclerosis]

@en

P2093

K Ruprecht

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

Thrombotic microangiopathy associated with interferon beta

Evidence for a two-stage disability progression in multiple sclerosis

Fingolimod-associated macular edema: incidence, detection, and management.

Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.

P2888

s00115-015-4338-1

P304

1031-42; quiz 1043-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00115-015-4338-1

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Friedemann Paul

P577

2015-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26253589

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

multiple sclerosis